Furazolidone Containing Regimens in Eradication of Helicobacter Pylori

Phase 3

• Conditions: Peptic Ulcer Disease(H.Pylori Eradication).; Gastric ulcer, Duodenal ulcer, Gastritis,unspecified ,Duodenitis; K25,K26, K

• Registration Number: IRCT2013120715701N1
• Lead Sponsor: Vice Chancellor for Research, Mazandaran university of medical scienses

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 372

Inclusion Criteria

Inclusion criteria : Helicobacter pylori infected duodenal ulcer; gastric ulcer;Gastric Erosion ;Deudenal Erosion;Age >18 year old.
Exclusion criteria :pregnancy ;lactation ; history of previous H.pylori eradication ; taking antibiotics and/or bismuth and/or non-steroidal anti inflammatory drugs during the previous four weeks; concomitant use of anticoagulant or corticosteroid;consuming substantial amounts of alcohol;,history of gastric surgery; significant underlying disease such as; liver;,renal; pulmonary; cardiac disease and neoplasms ; G6PD deficiency ;history of drug allergy to any medication in this study. .

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Helicobacter.pylori eradication rate. Timepoint: 2 months after the completion of treatment courser. Method of measurement: Urea Breath Test.

Secondary Outcome Measures

Name	Time	Method
Adverse effect of Drugs. Timepoint: Daily recording during and after the treatment course. Method of measurement: Medical history and record sheet.